Newron Pharmaceuticals SpA (NP5) Q2 2023 Earnings Report
DE:NP5 Q2 2023 EPS Results
- Actual EPS
- -EUR 0.39
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.48
DE:NP5 Q2 2023 Revenue Results
- Actual Revenue
- EUR 5.84M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +85.45%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/04/2023
- Time
- Before Open
- Conference Call
- Friday, August 4, 2023
DE:NP5 Upcoming Earnings
Newron Pharmaceuticals SpA's next earnings date is estimated for March 16, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:NP5 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 16, 2027 | 2026 (Q4) | -0.77- | -0.66 | ― | ― |
| Sep 22, 2026 | 2026 (Q2) | -0.19-0.80 | 0 | ― | |
| Mar 24, 2026 | 2025 (Q4) | -0.08-0.66 | 1.2 | -154.95% (-1.86) | |
| Sep 16, 2025 | 2025 (Q2) | -0.410.00 | -0.51 | 100.00% (+0.51) | |
| Apr 01, 2025 | 2024 (Q4) | ―1.29 | -0.54 | 341.16% (+1.83) | |
| Sep 19, 2024 | 2024 (Q2) | ―-0.51 | -0.39 | -30.77% (-0.12) | |
| Mar 19, 2024 | 2023 (Q4) | ―-0.54 | -0.52 | -2.47% (-0.01) | |
| Aug 04, 2023 | 2023 (Q2) | ―-0.39 | -0.48 | 18.75% (+0.09) | |
| Mar 14, 2023 | 2022 (Q4) | ―-0.52 | -0.38 | -39.26% (-0.15) | |
| Sep 15, 2022 | 2022 (Q2) | ―-0.48 | -0.51 | 5.88% (+0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
